Strategic Global Advisors, LLC Astrazeneca PLC Transaction History
Strategic Global Advisors, LLC
- $542 Million
- Q4 2024
A detailed history of Strategic Global Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Strategic Global Advisors, LLC holds 9,243 shares of AZN stock, worth $690,359. This represents 0.11% of its overall portfolio holdings.
Number of Shares
9,243
Previous 10,091
8.4%
Holding current value
$690,359
Previous $786,000
23.03%
% of portfolio
0.11%
Previous 0.16%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,357Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.51 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.06 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.8 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.77 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.79 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $231B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...